<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="64086">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02271620</url>
  </required_header>
  <id_info>
    <org_study_id>759/25569(EC3)</org_study_id>
    <nct_id>NCT02271620</nct_id>
  </id_info>
  <brief_title>The Prevalence and Clinical Characteristics of Children With Local Allergic Rhinitis</brief_title>
  <official_title>The Prevalence and Clinical Characteristics of Children With Local Allergic Rhinitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mahidol University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mahidol University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      -  To determine prevalence of local allergic rhinitis (LAR)

        -  To evaluate clinical characteristic and severity of local allergic rhinitis

        -  To measure changing of tryptase and Specific IgE for Dermatophagoides pteronyssinus
           (Dp) after nasal allergen provocation test (NAPT)
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Children 8-18 years with NAR were recruited. A NAPT with Der p 1 solutions (NAPT-DP) at 200
      AU/mL, 600 AU/mL and 2000 AU/mL at 15-minute interval was performed, respectively. The
      immediate responses to NAPT-DP were assessed using symptoms score, peak nasal inspiratory
      flow (PNIF) and acoustic rhinometry (ARM). The nasal tryptase and sIgE-DP were measured at
      baseline, 15 min and 1 h after positive NAPT-DP. Allergic rhinitis (AR) patients were used
      as positive control.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2014</start_date>
  <completion_date type="Anticipated">April 2016</completion_date>
  <primary_completion_date type="Anticipated">January 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>prevalence of local allergic rhinitis (LAR)</measure>
    <time_frame>1 year</time_frame>
    <description>positive nasal allergen provocation test with Der p1</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">53</enrollment>
  <condition>Other Allergic Rhinitis</condition>
  <arm_group>
    <arm_group_label>nonallergic rhinitis</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>nonallergic rhinitis nasal allergen provocation test</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>nasal allergen provocation test</intervention_name>
    <description>nasal allergen provocation test</description>
    <arm_group_label>nonallergic rhinitis</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Children 8-15 years who were diagnosed with nonallergic rhinitis (NAR) at least 1
             year

          -  No respiratory infections in the previous 4 weeks

          -  No following treatment of

          -  systemic corticosteroid 4 weeks

          -  intranasal corticosteroid 2 weeks

          -  oral antihistamine 1 week

          -  leukotriene antagonist 1 week

        Exclusion Criteria:

          -  Patients with underlying disease:

          -  chronic rhinosinusitis and nasal polyp

          -  immunological disease

          -  chronic renal disease

          -  hepatobiliary disease

          -  cardiovascular disease

          -  cancer

          -  Parental withdraw consent

          -  Patient with uncontrolled asthma, peak expiratory flow rate (PEFR) &lt; 80% of predicted
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>8 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Orathai Piboonpocanun, assoc. prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>66815818803</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Orathai Piboonpocanun, assoc. prof.</last_name>
    <phone>66815818803</phone>
    <email>jirapongo@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Pichittra Buntarickpornpan, MD</last_name>
    <phone>66869688630</phone>
    <email>pichittra.b@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Division of allergy and immunology, Department of pediatric, Siriraj Hospital</name>
      <address>
        <city>Bangkoknoi</city>
        <state>Bangkok</state>
        <zip>10700</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Orathai Piboonpocanun, Assoc. Prof.</last_name>
      <phone>66815818803</phone>
      <email>jirapongo@yahoo.com</email>
    </contact>
    <contact_backup>
      <last_name>Pichittra Buntarickpornpan, MD</last_name>
      <phone>66869688630</phone>
      <email>pichittra.b@gmail.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Division of Allergy and Immunology, Department of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University</name>
      <address>
        <city>Bangkok</city>
        <zip>10700</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Orathai Piboonpocanun, Assoc.Prof.</last_name>
      <phone>662-419-7000</phone>
      <phone_ext>5942</phone_ext>
      <email>jirapongo@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Orathai Piboonpocanun, Assoc.Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>April 2015</verification_date>
  <lastchanged_date>April 15, 2015</lastchanged_date>
  <firstreceived_date>September 9, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mahidol University</investigator_affiliation>
    <investigator_full_name>Orathai Piboonpocanun</investigator_full_name>
    <investigator_title>Division of allergy and immunology</investigator_title>
  </responsible_party>
  <keyword>1 prevalence</keyword>
  <keyword>2 children</keyword>
  <keyword>3 local allergic rhinitis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Rhinitis, Allergic</mesh_term>
    <mesh_term>Rhinitis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
